Labor induction in third trimester non-viable fetus.

Induction of labor intra-uterine fetal demise non-viable fetus oxytocin prostaglandin E2 termination of pregnancy third-trimester transcervical foley catheter

Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 17 10 2022
medline: 20 1 2023
entrez: 16 10 2022
Statut: ppublish

Résumé

We aimed to assess the efficacy of three different labor induction methods for non-viable third-trimester fetuses. This retrospective cohort study included women who had an intra-uterine fetal death or termination of pregnancy at or after 28 weeks of gestation and underwent labor induction by either transcervical foley catheter and concomitant oxytocin infusion or regular doses of vaginal Prostin Between January 2017 to June 2020, 107 women met the inclusion criteria. 25 women underwent induction of labor using transcervical foley catheter, 44 using Propess Cervical foley catheter with concomitant oxytocin infusion is the most effective method for induction of labor in third trimester non-viable in fetus compared to PGE2.

Identifiants

pubmed: 36244686
doi: 10.1080/14767058.2022.2134768
doi:

Substances chimiques

Oxytocin 50-56-6
Oxytocics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10530-10534

Auteurs

Emmanuel Attali (E)

Lis Hospital for Women, Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Guy Kern (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yuval Fouks (Y)

Lis Hospital for Women, Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Lee Reicher (L)

Lis Hospital for Women, Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ariel Many (A)

Lis Hospital for Women, Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ishai Levin (I)

Lis Hospital for Women, Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yariv Yogev (Y)

Lis Hospital for Women, Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Aviad Cohen (A)

Lis Hospital for Women, Sourasky Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH